Treating Tobacco Addiction — Nicotine or No Nicotine?
- 23 October 1997
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (17) , 1230-1231
- https://doi.org/10.1056/nejm199710233371710
Abstract
Nicotine has been the mainstay of pharmacotherapy for tobacco addiction, but other medications, such as the antidepressant drugs bupropion and nortriptyline, are also effective. These antidepressant agents are effective in patients without current depression. Identifying the mechanism by which such drugs help someone quit may increase our understanding of nicotine addiction. The availability of medications that do not contain nicotine provides physicians and other health care workers with new choices and decisions on the optimal approach to smoking cessation in their practices.The results of the first large clinical trial of bupropion as an aid to smoking cessation appear in . . .Keywords
This publication has 14 references indexed in Scilit:
- A Comparison of Sustained-Release Bupropion and Placebo for Smoking CessationNew England Journal of Medicine, 1997
- Development of Major Depressive Disorder During Smoking-Cessation TreatmentThe Journal of Clinical Psychiatry, 1996
- Inhibition of monoamine oxidase B in the brains of smokersNature, 1996
- Is Clonidine an Effective Smoking Cessation Therapy?Drugs, 1995
- Recycling with nicotine patches in smoking cessationAddiction, 1993
- Smoking and Major DepressionArchives of General Psychiatry, 1993
- Smoking, smoking cessation, and major depressionJAMA, 1990
- Depression and the dynamics of smoking. A national perspectiveJAMA, 1990
- Depression and depressive symptoms in smoking cessationComprehensive Psychiatry, 1990
- Drs. Edwards and Murphy ReplyAmerican Journal of Psychiatry, 1989